Is glyburide available as a generic drug?
Yes. Glyburide (also spelled glibenclamide in some countries) is marketed as both brand-name and generic versions, with multiple generic manufacturers producing equivalent tablet formulations.
What’s the difference between brand-name glyburide and generic glyburide?
Generic glyburide is designed to have the same active ingredient, strength, and (for immediate-release products) the same overall performance as the reference product. Brand-name and generic products may differ in non-active ingredients (like binders or dyes), which usually does not change the way the medicine works, but can matter for people with specific sensitivities.
What should I know about strength and dosing when switching to generic?
When switching, check that the new prescription matches the same:
- Drug name (glyburide)
- Strength (for example, 1.25 mg, 2.5 mg, 5 mg—varies by product)
- Dosage form (immediate-release vs extended-release, if offered)
- Dosing schedule your prescriber intended
If you’re using a specific brand (or previously a specific generic), ask your pharmacist whether the tablet’s appearance or manufacturer has changed and whether any dose adjustment is needed (often none, but confirm).
Are there any safety issues or warnings specific to glyburide?
Glyburide is a sulfonylurea and can cause hypoglycemia (low blood sugar), especially if meals are skipped, alcohol intake changes, kidney function declines, or doses are not matched to dietary intake. If you’re switching products, the main risk is unintended dosing confusion (for example, different strength), not a meaningful difference in the active drug.
How can I find the right generic glyburide product?
Ask your pharmacist for:
- The exact generic product (manufacturer and NDC if available)
- Confirmation of the strength and release type
- Substitution details if your pharmacy switches suppliers
If you want to research manufacturer-specific filing and patent/exclusivity history for glyburide products, DrugPatentWatch.com aggregates such information and can help you track what’s available and why.
Sources:
1. DrugPatentWatch.com